Rating Change
Cantor Fitzgerald reiterated its Neutral rating on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) on November 06, 2026.
reiterateNASDAQ:RIGL
Cantor Fitzgerald Reiterates Neutral Rating on Rigel Pharmaceuticals, Inc. (RIGL)
Cantor Fitzgerald reiterated its Neutral rating on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) on November 06, 2026.
At publication ·
What changed
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) · reiterate
- Firm
- Cantor Fitzgerald
- Rating
- Neutral to Neutral
- Price at event
- $39.65
- Market capitalization
- $751.7M
At a glance
Key takeaways
- Cantor Fitzgerald maintained a Neutral rating on Rigel Pharmaceuticals (RIGL) on November 6, 2026, with the stock trading at $39.65.
Market Context
Rigel Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $39.65 with a market capitalization of $751.7M. The stock has gained 4.8% over the past 52 weeks.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Rigel Pharmaceuticals, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Rigel Pharmaceuticals, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 06, 2026 | Cantor Fitzgerald | Neutral | N/A |
| Oct 19, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 17, 2026 | Piper Sandler | Neutral | N/A |
| Aug 14, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 02, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RIGL Stock Page
Frequently Asked Questions
What does the Neutral rating mean for RIGL?
A rating of Neutral from Cantor Fitzgerald reflects the analyst's outlook on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RIGL forecast page.